Arsun Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.50 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.45 Cr
- Revenue Growth 4.89%
- Profit Growth 231.04%
- Ebitda 73.11%
- Net Worth 28.75%
- Total Assets 10.14%
About Arsun Healthcare
Arsun Healthcare Private Limited (AHPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 March 2011 and has a history of 13 years and ten months. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.45 Cr.
Deepa Ganesan, Manimegalai Namachivayam, and Sutha Sekar serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TZ2011PTC016905
-
Company No.
016905
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Mar 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Arsun Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepa Ganesan
|
Director | 01-Jul-2011 | Current |
|
Manimegalai Namachivayam
|
Director | 01-Jul-2011 | Current |
|
Sutha Sekar
|
Director | 01-Jul-2011 | Current |
Financial Performance of Arsun Healthcare.
Arsun Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.89% increase. The company also saw a substantial improvement in profitability, with a 231.04% increase in profit. The company's net worth Soared by an impressive increase of 28.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arsun Healthcare?
In 2022, Arsun Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹14.48 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.75 Cr
- Hdfc Bank Limited : 0.58 Cr
- Dena Bank : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2023 | Others | ₹7.50 M | Open |
| 30 Sep 2022 | Hdfc Bank Limited | ₹1.78 M | Open |
| 08 Sep 2022 | Hdfc Bank Limited | ₹4.00 M | Open |
| 27 May 2016 | Dena Bank | ₹1.20 M | Open |
How Many Employees Work at Arsun Healthcare?
Arsun Healthcare has a workforce of 35 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arsun Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arsun Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
